From bench to clinic: ten ways CPI de-risks and accelerates viral vector and viral vaccine development

From bench promise to clinical reality, without the usual scale-up setbacks.

This practical guide shows how viral vector teams turn complex biology into robust, regulator-ready manufacturing processes. Discover ten proven ways to strengthen process understanding, generate scale-relevant data, build defensible CMC packages, and avoid costly rework at IND/CTA milestones. If you’re developing AAV, lentiviral vectors, or viral-vectored vaccines and need to accelerate timelines while protecting quality and compliance, this is essential reading for de-risking your path to clinic.